Recent Operational Highlights
- Entered into a non-exclusive business development and sales agency agreement in
Japan withONE AI, Co., Ltd. (“ONE AI”) - As of
September 30, 2026 ,HeartCore was engaged with 16 Go IPO clients, including 6 clients currently in various stages of preparation for potential initial public offerings andU.S . exchange listings. - Announced and completed the transfer of the Company’s 51% equity interest in
HeartCore Luvina Vietnam Company Limited (“HeartCore Luvina”) toLuvina Software Joint Stock Company forJPY 29,000,000 (approximately$184,000 ). Together with theJune 2026 divestiture ofSigmaways, Inc. , the transaction concludes the Company’s exit from software development services and concentrates its operations on Go IPO consulting, capital markets advisory, and financial services.
Management Commentary
“The Nasdaq listing environment remains selective, and a number of our clients have extended their IPO timelines as they work to satisfy stricter exchange and regulatory requirements. We continue to prioritize clients that we believe demonstrate stronger fundamentals, organizational readiness, and a clear path to a
“Beyond our core business, just last week, we announced a new business development and sales agency agreement with ONE AI. Under this agreement, we will support ONE AI’s commercial expansion into the Japanese robotics market. Importantly, the agreement introduces an additional commission-based revenue stream, further diversifying our revenue base as we continue to navigate the current
“Looking ahead, we intend to maintain disciplined cost management as we work to convert our pipeline into new engagements and listing milestones. With a simpler structure in place, we expect our results going forward to more clearly reflect the performance of our core business.”
Third Quarter 2026 Financial Results
Revenues were
Gross profit was
Operating expenses were
Net loss was
Adjusted EBITDA was
Nine Months Ended
Revenues were
Gross loss was
Operating expenses were
Net loss was
Adjusted EBITDA was
As of
About
Non-GAAP Financial Measures
This document includes references to Adjusted EBITDA, which is a non-GAAP financial measure. For the purposes of this presentation, Adjusted EBITDA is calculated by adjusting net loss to exclude depreciation and amortization, changes in fair value of investments in marketable securities, changes in fair value of investment in warrants, changes in fair value of derivative liability, interest income, interest expenses, other income, and other expenses.
This measure is presented as supplemental information and is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the
Management believes that Adjusted EBITDA provides useful information to investors by highlighting the Company’s core operational performance, excluding non-cash and non-recurring items. However, non-GAAP financial measures have limitations and should not be considered in isolation or as a substitute for financial results prepared in accordance with GAAP.
For the three months ended
| Item | 2026 | 2025 |
| Net income (loss) | ||
| (+) Depreciation | ||
| (+) Changes in fair value of investments in marketable securities | ||
| (+) Changes in fair value of investment in warrants | ||
| (+) Changes in fair value of derivative liability | ||
| (+) Interest income | ||
| (+) Interest expenses | ||
| (+) Other income | ||
| (+) Other expenses | ||
| Adjusted EBITDA |
For the nine months ended
| Item | 2026 | 2025 |
| Net loss | ||
| (+) Depreciation | ||
| (+) Changes in fair value of investments in marketable securities | ||
| (+) Changes in fair value of investment in warrants | ||
| (+) Changes in fair value of derivative liability | ||
| (+) Interest income | ||
| (+) Interest expenses | ||
| (+) Other income | ||
| (+) Other expenses | ||
| Adjusted EBITDA |
Note: Figures in the tables above are rounded to the nearest
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity.
HeartCore Investor Relations Contact:
HTCR@gateway-grp.com
(949) 574-3860
| UNAUDITED CONSOLIDATED BALANCE SHEETS | |||||||
| 2026 | 2025 | ||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 976,594 | $ | 1,530,967 | |||
| Accounts receivable | 32,853 | - | |||||
| Investments in marketable securities | 1,380,553 | 3,690,187 | |||||
| Prepaid expenses | 82,351 | 127,242 | |||||
| Deferred offering costs | 250,000 | 250,000 | |||||
| Other current assets | 144,079 | 188,525 | |||||
| Current assets of discontinued operations | - | 1,337,673 | |||||
| Proceeds receivable from sale of discontinued operations | 483,082 | 1,291,298 | |||||
| Total current assets | 3,349,512 | 8,415,892 | |||||
| Non-current assets: | |||||||
| Property and equipment, net | 255,872 | 275,465 | |||||
| Operating lease right-of-use assets | 352,524 | 16,986 | |||||
| Long-term investment in warrants | 130,916 | 280,924 | |||||
| Long-term loan receivable | 258,859 | - | |||||
| Deferred tax assets | 23,006 | 23,121 | |||||
| Security deposits | 276,199 | 278,342 | |||||
| Other non-current assets | 286 | - | |||||
| Non-current assets of discontinued operations | - | 33,752 | |||||
| Long-term proceeds receivable from sale of discontinued operations | 3,496,039 | 3,736,995 | |||||
| Total non-current assets | 4,793,701 | 4,645,585 | |||||
| Total assets | $ | 8,143,213 | $ | 13,061,477 | |||
| LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable and accrued expenses | $ | 454,345 | $ | 275,412 | |||
| Accrued payroll and other employee costs | 41,859 | 41,073 | |||||
| Due to related party | 423 | 285 | |||||
| Insurance premium financing | 33,736 | 13,430 | |||||
| Operating lease liabilities, current | 284,622 | 16,986 | |||||
| Income tax payables | 20,564 | 1,038 | |||||
| Deferred revenue | 438,862 | 676,216 | |||||
| Derivative liability | 62,507 | 121,719 | |||||
| Other current liabilities | 530,070 | 521,607 | |||||
| Current liabilities of discontinued operations | - | 1,833,294 | |||||
| Total current liabilities | 1,866,988 | 3,501,060 | |||||
| Non-current liabilities: | |||||||
| Operating lease liabilities, non-current | 71,912 | - | |||||
| Deferred tax liabilities | 211,795 | 1,039,181 | |||||
| Non-current liabilities of discontinued operations | - | 448,376 | |||||
| Total non-current liabilities | 283,707 | 1,487,557 | |||||
| Total liabilities | 2,150,695 | 4,988,617 | |||||
| Shareholders' equity: | |||||||
| Preferred shares, | 351,712 | 691,858 | |||||
| Common shares, | 151 | 127 | |||||
| Additional paid-in capital | 22,309,504 | 21,902,169 | |||||
| Accumulated deficit | (16,640,902 | ) | (12,965,525 | ) | |||
| Accumulated other comprehensive loss | (27,947 | ) | (58,497 | ) | |||
| Total | 5,992,518 | 9,570,132 | |||||
| Non-controlling interests | - | (1,497,272 | ) | ||||
| Total shareholders' equity | 5,992,518 | 8,072,860 | |||||
| Total liabilities and shareholders' equity | $ | 8,143,213 | $ | 13,061,477 | |||
| UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) | |||||||||
| For the Nine Months | |||||||||
| Ended | |||||||||
| 2026 | 2025 | ||||||||
| Revenues | $ | 269,852 | $ | 1,666,519 | |||||
| Cost of revenues | 529,562 | 331,962 | |||||||
| Gross profit (loss) | (259,710 | ) | 1,334,557 | ||||||
| Operating expenses: | |||||||||
| Selling expenses | 104,021 | 296,632 | |||||||
| General and administrative expenses | 2,986,544 | 2,488,822 | |||||||
| Total operating expenses | 3,090,565 | 2,785,454 | |||||||
| Income (loss) from continuing operations | (3,350,275 | ) | (1,450,897 | ) | |||||
| Other income (expenses): | |||||||||
| Changes in fair value of investments in marketable securities | (375,367 | ) | (908,416 | ) | |||||
| Changes in fair value of investment in warrants | (7,493 | ) | (74,109 | ) | |||||
| Changes in fair value of derivative liability | (630 | ) | (9,679 | ) | |||||
| Interest income | 1,100 | 3,966 | |||||||
| Interest expenses | (6,386 | ) | (8,569 | ) | |||||
| Other income | 186,056 | 45,632 | |||||||
| Other expenses | (361,838 | ) | (193 | ) | |||||
| Total other income (expenses) | (564,558 | ) | (951,368 | ) | |||||
| Income (loss) from continuing operations before income tax expense (benefit) | (3,914,833 | ) | (2,402,265 | ) | |||||
| Income tax expense (benefit) | (766,504 | ) | 33,377 | ||||||
| Net income (loss) from continuing operations | (3,148,329 | ) | (2,435,642 | ) | |||||
| Income (loss) from discontinued operations, net of income tax | (644,329 | ) | 710,942 | ||||||
| Net income (loss) | (3,792,658 | ) | (1,724,700 | ) | |||||
| Less: income (loss) from discontinued operations attributable to non-controlling interests | (117,281 | ) | (171,682 | ) | |||||
| Net income (loss) attributable to | (3,675,377 | ) | (1,553,018 | ) | |||||
| Dividends accrued on Series A convertible preferred shares | (62,530 | ) | (56,833 | ) | |||||
| Net income (loss) attributable to | $ | (3,737,907 | ) | $ | (1,609,851 | ) | |||
| Other comprehensive income (loss): | |||||||||
| Foreign currency translation adjustment | (72,706 | ) | 9,668 | ||||||
| Cumulative translation adjustment reclassified into earnings due to disposal of discontinued operations | 94,751 | - | |||||||
| Total comprehensive income (loss) | (3,770,613 | ) | (1,715,032 | ) | |||||
| Less: comprehensive income (loss) attributable to non-controlling interests | (125,786 | ) | (175,353 | ) | |||||
| Comprehensive income (loss) attributable to | $ | (3,644,827 | ) | $ | (1,539,679 | ) | |||
| Net income (loss) from continuing operations attributable to | |||||||||
| Basic | $ | (2.30 | ) | $ | (2.22 | ) | |||
| Diluted | $ | (2.30 | ) | $ | (2.22 | ) | |||
| Income (loss) from discontinued operations per common share* | |||||||||
| Basic | $ | (0.38 | ) | $ | 0.78 | ||||
| Diluted | $ | (0.38 | ) | $ | 0.78 | ||||
| Net income (loss) attributable to | |||||||||
| Basic | $ | (2.68 | ) | $ | (1.43 | ) | |||
| Diluted | $ | (2.68 | ) | $ | (1.43 | ) | |||
| Weighted average common shares outstanding* | |||||||||
| Basic | 1,395,177 | 1,124,484 | |||||||
| Diluted | 1,395,177 | 1,124,484 | |||||||
| UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
| For the Nine Months | ||||||||
| Ended | ||||||||
| 2026 | 2025 | |||||||
| Cash flows from operating activities of continuing operations: | ||||||||
| Net loss | $ | (3,792,658 | ) | $ | (1,724,700 | ) | ||
| Income (loss) from discontinued operations, net of income tax | (644,329 | ) | 710,942 | |||||
| Net loss from continuing operations | (3,148,329 | ) | (2,435,642 | ) | ||||
| Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations: | ||||||||
| Depreciation expense | 23,023 | 36,994 | ||||||
| Loss on disposal of property and equipment | - | 116,981 | ||||||
| Non-cash lease expense | 195,691 | 28,167 | ||||||
| Gain on termination of lease | - | (9,059 | ) | |||||
| Deferred income taxes | (796,046 | ) | 29,680 | |||||
| Stock-based compensation | 2,031 | 69,222 | ||||||
| Warrants received as noncash consideration | - | (837,913 | ) | |||||
| Changes in fair value of investments in marketable securities | 375,367 | 908,416 | ||||||
| Changes in fair value of investment in warrants | 7,493 | 74,109 | ||||||
| Changes in fair value of derivative liability | 630 | 9,679 | ||||||
| Gain on settlement of asset retirement obligations | - | (45,873 | ) | |||||
| Changes in assets and liabilities: | ||||||||
| Accounts receivable | (32,826 | ) | - | |||||
| Prepaid expenses | 152,391 | 114,556 | ||||||
| Other assets | 93,367 | 137,050 | ||||||
| Accounts payable and accrued expenses | 178,373 | (98,030 | ) | |||||
| Accrued payroll and other employee costs | 988 | (43,430 | ) | |||||
| Due to related party | 138 | - | ||||||
| Operating lease liabilities | (191,710 | ) | (21,135 | ) | ||||
| Income tax payables | 19,382 | (97,537 | ) | |||||
| Deferred revenue | (237,354 | ) | (278,421 | ) | ||||
| Other liabilities | 8,458 | (4 | ) | |||||
| Net cash flows used in operating activities of continuing operations | (3,348,933 | ) | (2,342,190 | ) | ||||
| Cash flows from investing activities of continuing operations: | ||||||||
| Purchases of property and equipment | (4,931 | ) | - | |||||
| Proceeds from sale of marketable securities | 2,076,782 | 1,071,732 | ||||||
| Advances on loan receivable | (256,932 | ) | - | |||||
| Proceeds from sales of discontinued operations, net of cash divested | 825,663 | - | ||||||
| Net cash flows provided by investing activities of continuing operations | 2,640,582 | 1,071,732 | ||||||
| Cash flows from financing activities of continuing operations: | ||||||||
| Payments for finance lease | - | (12,692 | ) | |||||
| Repayment of insurance premium financing | (87,694 | ) | (103,303 | ) | ||||
| Proceeds from issuance of common shares related to at the market offering agreement | - | 30,445 | ||||||
| Proceeds from collection of subscription receivable | - | 103,942 | ||||||
| Proceeds from exercise of stock options | - | 117,000 | ||||||
| Proceeds from issuance of Series A convertible preferred shares and common shares related to securities purchase agreement, net of share issuance costs | - | 1,800,000 | ||||||
| Net cash flows provided by (used in) financing activities of continuing operations | (87,694 | ) | 1,935,392 | |||||
| Cash flows from discontinued operations: | ||||||||
| Net cash flows used in operating activities of discontinued operations | (119,498 | ) | (511,096 | ) | ||||
| Net cash flows provided by (used in) investing activities of discontinued operations | (1,432 | ) | 29,222 | |||||
| Net cash flows used in financing activities of discontinued operations | (22,134 | ) | (305,990 | ) | ||||
| Net cash flows used in discontinued operations | (143,064 | ) | (787,864 | ) | ||||
| Effect of exchange rate changes | (70,259 | ) | 26,577 | |||||
| Net change in cash and cash equivalents | (1,009,368 | ) | (96,353 | ) | ||||
| Cash and cash equivalents - beginning of the period | 1,985,962 | 2,121,089 | ||||||
| Cash and cash equivalents - end of the period | $ | 976,594 | $ | 2,024,736 | ||||
| Supplemental cash flow disclosures: | ||||||||
| Interest paid | $ | 32,583 | $ | 88,321 | ||||
| Income taxes paid | $ | 14,197 | $ | 131,118 | ||||
| Non-cash investing and financing transactions: | ||||||||
| Insurance premium financing | $ | 108,000 | $ | 139,500 | ||||
| Warrants converted to marketable securities | $ | 142,515 | $ | 388,260 | ||||
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | $ | 552,577 | $ | 23,495 | ||||
| Issuance of common shares related to equity purchase agreement | $ | - | $ | 250,000 | ||||
| Dividends accrued on Series A convertible preferred shares | $ | 62,530 | $ | 56,833 | ||||
| Issuance of common shares for dividends on Series A convertible preferred shares | $ | 67,870 | $ | - | ||||
| Series A convertible preferred shares converted to common shares | $ | 340,146 | $ | - | ||||
Source: 